HIV/AIDS Research:
Its History & Future
October 13 - 16, 2016


Robert Gallo, Institute of Human Virology, University of Maryland School of Medicine, Baltimore
John Coffin, Tufts University
Mila Pollock, Cold Spring Harbor Laboratory
Bruce Walker, Ragon Institute of MGH, MIT and Harvard

Never before have the pioneers of the science of retroviruses, the discoverers of human retroviruses, the developers of HIV/AIDS therapeutics, and key figures in important research findings come together to discuss the history and future of the field.  Together, this interdisciplinary group will review the key scientific, epidemiological, and clinical discoveries that created this field, delve into the present science of HIV/AIDS, and discuss and debate the paths to the future control of this global pandemic, which, tragically, has persisted for more than 35 years.

The meeting will begin at 7:30 pm on Thursday, October 13, and finish in the late afternoon on Sunday, October 16, 2016.


  • The Story of Animal Retroviruses
  • The Pandemic Begins: Early Discoveries
  • Human and Primate Retroviruses, HIV Origin
  • The Extraordinary Virus: Molecular Biology
  • Immunology and Prevention
  • Antiretroviral Therapy
  • Pathogenesis and Prospects
Confirmed Speakers

David Baltimore, Caltech
Daniel Barouch, Beth Israel Deaconess Medical Center
Francoise Barrè-Sinoussi,
Institut Pasteur, Paris, France
John Bartlett, Johns Hopkins University School of Medicine
Edward Berger, National Institute of Allergy and Infectious Diseases (NIAID)
Paul Bieniasz, Aaron Diamond AIDS Research Center
Samuel Broder, Intrexon Corporation
Dennis Burton, The Scripps Research Institute
John Coffin, Tufts University
Jon Cohen, Science Magazine
Lawrence Corey, Fred Hutchinson Cancer Research Center
James Curran, Emory University
Ronald Desrosiers, University of Miami, Miller School of Medicine
Michael Emerman, Fred Hutchinson Cancer Research Center
Emilio Emini, Bill & Melinda Gates Foundation
Myron Essex, Harvard University
Anthony Fauci, National Institute of Allergy and Infectious Diseases (NIAID)
Genoveffa Franchini, National Cancer Institute
Robert Gallo, Institute of Human Virology, University of Maryland School of Medicine, Baltimore
Stephen Goff, Columbia University
Michael Gottlieb, David Geffen School of Medicine, UCLA
Glenda Gray, South African Medical Research Council, South Africa
Warner Greene, Gladstone Institute of Virology & Immunology/UCSF
Ashley Haase, University of Minnesota
Beatrice Hahn, University of Pennsylvania
Victoria Harden, NIH, Office of NIH History & Stetten Museum (Founding Director, Emerita)
Mark Harrington, Treatment Action Group
Barton Haynes, Duke University School of Medicine
Daria Hazuda, Merck Research Labs
Staffan Hildebrand, Face of AIDS Foundation
Sharon Hillier, Magee-Womens Hospital of UPMC
David Ho, The Rockefeller University
Sandra Lehrman, Merck Research Labs
Sharon Lewin, University of Melbourne
Jeffrey Lifson, National Cancer Institute at Frecerick
Michael Malim, King’s College London
John Martin, Gilead Sciences, Inc.
John Mellors, University of Pittsburgh
Peter Mugyenyi, Joint Clinical Research Centre, Uganda
Julie Overbaugh, Fred Hutchinson Cancer Research Center
Martine Peeters, IRD (Institut de Recherche pour le Development) France
Alan Perelson, Los Alamos National Laboratory, Santa Fe Institute
Mila Pollock, Cold Spring Harbor Laboratory (CSHL)
Robert Redfield, IHV, University of Maryland School of Medicine
Andrew Rice, Baylor College of Medicine
Douglas Richman, University of California, San Diego
Ruth Ruprecht, Texas Biomedical Research Institute
Raymond Schinazi, Emory University
George Shaw, University of Pennsylvania
Robert Siliciano, Johns Hopkins University
Anna Marie Skalka, Fox Chase Cancer Center
Joseph Sodroski, Harvard University
Marty St. Clair, ViiV Healthcare, US Headquarters, NC
Anders Vahlne, Karolinska Institutet, Sweden
Harold Varmus, Weill Cornell Medical College
Paul Volberding, UCSF Global Health Sciences/ARI
Bruce Walker, Ragon Institute of MGH, MIT and Harvard
Robin Weiss, University College London (UCL)
Flossie Wong-Staal, Professor Emeritus UC San Diego/Board Member United Biomedical, Inc.
Michael Worobey, University of Arizona
Susan Zolla-Pazner, Mount Sinai School of Medicine

Public program (documentary, discussions):  Sunday, October 16, 2016, 2:00-4:00 pm

For these unique meetings, we invite speakers who made many of the seminal discoveries that began the field, as well as those who are working on the topic now.  We also invite historians of science who have examined the topic, setting it in its scientific and societal context.  Like the previous meetings in the series, this meeting will provide an excellent opportunity to look in-depth at a topic and share the stories that are often missing from academic accounts.

We anticipate the meeting will interest a broad range of individuals, including scientists, clinicians, historians, activists, and science journalists

While abstracts are NOT being accepted for this meeting, we invite participants who would like to present posters at the meeting to alert us via email to Val Pakaluk.  Plan on a maximum size of 4ft x 4ft (1.22m x 1.22m) for your poster.

We have applied for funds from industry and other sponsors to partially offset attendance costs for those in real financial need.  Apply in writing to Val Pakaluk stating your need for financial support.

We look forward to seeing you at Cold Spring Harbor in October.

Financial support provided by:  Bill & Melinda Gates Foundation, Gilead Sciences Inc., Merck & Co., National Institute of Allergy & Infectious Diseases (part of the National Institutes of Health)

The CSHL/Genentech Center Conferences on the History of Molecular Biology & Biotechnology aim to explore important themes of discovery in the biological sciences, bringing together scientists who made many of the seminal discoveries that began the field with others whose interests may include the current status of the field, the historical progress of the field, and/or the application of these techniques and approaches in biotechnology and medicine.

Previous meetings in the series have included:

  • Biotechnology: Past, Present & Future (2008)
  • History of Restriction Enzymes (2013)
  • Messenger RNA: From Discovery to Synthesis and Regulation in Bacteria and Eukaryotes (2014)
  • Plasmids: History & Biology (2014)
  • The Evolution of Sequencing Technology: A Half-Century of Progress (2015)

Regular Pricing
Academic Package $1,140
Graduate/PhD Student Package $955
Corporate Package $1,445
Academic/Student No-Housing Package $780
Corporate No-Housing Package $975

Regular packages are all inclusive and cover registration, food, housing, parking, wine-and-cheese party, lobster banquet, etc. No Housing packages include all costs except housing. Full payment is due 4 weeks prior to the meeting.